TCLA Premium: Now half price (£30/month). Applications, interviews, commercial awareness + 700+ examples.
Join →

Reply to thread

Message: <blockquote data-quote="Afraz Akhtar" data-source="post: 231410" data-attributes="member: 43563"><p>I’m not going to pretend to know anything about something I have no idea of. Trust me, 8 months with Blackstone and I still can’t tell you the rationale behind a funds flow. Safe to say it’s not for me. However, one thing I repeatedly see with Debevoise is their industry specific knowledge is constantly commended. What’s interesting about this is that industry specific knowledge can sometimes translate to creative drafting for what seems to be very tedious funding documents - in a way that encourages investment whilst protecting the client. For example, they have a have a long standing relationship with Kelso, having most recently advised them on the formation of the Kelso Investment Associates XI fund and Kelso tend to create funds for investment in the healthcare space. I’d be curious to look into whether there are any concerns here with regards investment in healthcare e.g. is there less ROI on certain aspects of clinical measures that hinder investment - how are Debevoise forming funds that actually surpass the expected pool of money to be coming in here? How are they structuring the documents to appeal to investors. Is there a certain insight have that other firms maybe don’t? Seems like a long shot, but worth looking into. Work backwards and look at their success, scrutinise it in line with market concerns and consider what they did to alleviate them. Hope this helps, but if it didn’t, it may be my last post on funds at all.</p></blockquote><p></p>

Verification: Our company is called, "The Corporate ___ Academy". What is the missing word here?

Top Bottom

Search

Search

Reply to thread